Advances in myelin oligodendrocyte glycoprotein antibody-associated disease
10.3760/cma.j.issn.1673-4408.2022.05.004
- VernacularTitle:髓鞘少突胶质细胞糖蛋白抗体相关性疾病研究进展
- Author:
Hua XU
1
;
Jiwen WANG
Author Information
1. 上海交通大学医学院附属上海儿童医学中心 200127
- Keywords:
Myelin oligodendrocyte glycoprotein antibody-associated disease;
Inflammatory demyelinating disorder;
Pathogenesis
- From:
International Journal of Pediatrics
2022;49(5):302-306
- CountryChina
- Language:Chinese
-
Abstract:
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is one of inflammatory demyelinating disorders of the central nervous system.Due to the diverse and atypical clinical manifestations, positive rate of current detection methods is not high, and early diagnosis is difficult.This review aims to elucidate the research progress of the epidemiology, pathogenesis, clinical characteristics, diagnostic criteria, biological markers, treatment and prognosis of MOGAD, in order to improve the understanding of MOGAD for clinicians, so as to identify, treat and reduce the recurrence of MOGAD as early as possible.
